Teladoc Health, Inc. (TDOC) Stock
TDOC Key Statistics
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
CEO: Charles Divita. Company website
TDOC — Frequently Asked Questions
What is the TDOC stock price today?
Teladoc Health, Inc. (TDOC) trades at $6.30, up 0.32% on the day, as of Sep 20, 2026 15:00 UTC.
What is Teladoc Health, Inc.'s market cap?
Teladoc Health, Inc. has a market capitalisation of $1.14B, calculated from the live TDOC share price and shares outstanding.
What is the P/E ratio of TDOC?
TDOC has no meaningful price-to-earnings ratio: Teladoc Health, Inc. lost $0.99 per share over the last twelve months, and a P/E is only defined on positive earnings.
How much revenue does Teladoc Health, Inc. make?
Teladoc Health, Inc. generated revenue of $2.49B over the trailing twelve months, which puts the stock at 0.46 times sales.
What is the 52-week range for TDOC?
TDOC has traded between $4.40 and $9.89 over the past 52 weeks, and the last price is 36.3% below that high.
Is Teladoc Health, Inc. profitable?
No. Teladoc Health, Inc. is loss-making, with a net margin of -7.13% over the trailing twelve months.
What is the analyst price target for TDOC?
Wall Street analysts rate TDOC Hold, with an average price target of $8.83, 40.2% above the current price.
What sector is Teladoc Health, Inc. in?
Teladoc Health, Inc. is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US.
Who is the CEO of Teladoc Health, Inc.?
Charles Divita is the chief executive of Teladoc Health, Inc., which employs 5,124 people.
Where can I track TDOC in real time?
QFI Terminal shows TDOC with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See TDOC live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open TDOC in Terminal See plans